Genetic abnormalities detected in ependymomas by comparative genomic hybridisation

[1]  B. Harding,et al.  Gain of 1q and loss of 22 are the most common changes detected by comparative genomic hybridisation in paediatric ependymoma , 2001, Genes, chromosomes & cancer.

[2]  D. Brat,et al.  Chromosomal abnormalities subdivide ependymal tumors into clinically relevant groups. , 2001, The American journal of pathology.

[3]  D. Frappaz,et al.  Postoperative chemotherapy without irradiation for ependymoma in children under 5 years of age: a multicenter trial of the French Society of Pediatric Oncology. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  J. Crolla,et al.  Imbalances of chromosome 17 in medulloblastomas determined by comparative genomic hybridisation and fluorescence in situ hybridisation , 2000, Molecular pathology : MP.

[5]  A. Hui,et al.  Comparative genomic hybridization detects losses of chromosomes 22 and 16 as the most common recurrent genetic alterations in primary ependymomas. , 2000, Cancer genetics and cytogenetics.

[6]  D. Figarella-Branger,et al.  Prognostic factors in intracranial ependymomas in children. , 2000, Journal of neurosurgery.

[7]  D. Figarella-Branger,et al.  Cytogenetic study of 33 ependymomas. , 1999, Cancer genetics and cytogenetics.

[8]  E. Ballard,et al.  Karyotype studies in 18 ependymomas with literature review of 107 cases. , 1999, Cancer genetics and cytogenetics.

[9]  G. Reifenberger,et al.  Molecular genetic analysis of ependymal tumors. NF2 mutations and chromosome 22q loss occur preferentially in intramedullary spinal ependymomas. , 1999, The American journal of pathology.

[10]  D. Ellison,et al.  Comparative genomic hybridization and histological variation in primitive neuroectodermal tumours , 1999, British Journal of Cancer.

[11]  K. Lamborn,et al.  A multi-institutional retrospective study of intracranial ependymoma in children: identification of risk factors. , 1999, Journal of pediatric hematology/oncology.

[12]  Al‐Sarraj Molecular genetic analysis of non‐astrocytic gliomas , 1999, Histopathology.

[13]  A. Look,et al.  Chromosome arm 6q loss is the most common recurrent autosomal alteration detected in primary pediatric ependymoma , 1999, Genes, chromosomes & cancer.

[14]  J. Haase,et al.  Epidemiology and prognosis in children treated for intracranial tumours in Denmark 1960–1984 , 1998, Child’s Nervous System.

[15]  G. Perilongo,et al.  Intracranial ependymomas in children: a critical review of prognostic factors and a plea for cooperation. , 1998, Medical and pediatric oncology.

[16]  C. Bailey Comment: Intracranial ependymomas in children , 1998 .

[17]  D. Louis,et al.  PTEN mutations in gliomas and glioneuronal tumors , 1998, Oncogene.

[18]  L. Rorke,et al.  Survival and prognostic factors following radiation therapy and chemotherapy for ependymomas in children: a report of the Children's Cancer Group. , 1998, Journal of neurosurgery.

[19]  J. Biegel,et al.  Molecular cytogenetic studies of pediatric ependymomas , 1998, Journal of Neuro-Oncology.

[20]  H. Tanke,et al.  Comparative genomic hybridization in hypotriploid/hyperdiploid tumors. , 1997, Cytometry.

[21]  I. Pollack,et al.  The Molecular Biology of Ependymomas , 1997, Brain pathology.

[22]  P. Cogen,et al.  Molecular genetic analysis of chromosome arm 17p and chromosome arm 22q DNA sequences in sporadic pediatric ependymomas , 1996, Genes, chromosomes & cancer.

[23]  F. Gilles,et al.  Age-related changes in diagnoses, histological features, and survival in children with brain tumors: 1930-1979. The Childhood Brain Tumor Consortium. , 1995, Neurosurgery.

[24]  P. Gerszten,et al.  Intracranial ependymomas of childhood: long-term outcome and prognostic factors. , 1995, Neurosurgery.

[25]  J Piper,et al.  Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors , 1994, Genes, chromosomes & cancer.

[26]  D. Cochrane,et al.  Cytogenetic analysis of 109 pediatric central nervous system tumors. , 1993, Cancer genetics and cytogenetics.

[27]  B. Scheithauer,et al.  Cytogenetic and loss of heterozygosity studies in ependymomas, pilocytic astrocytomas, and oligodendrogliomas , 1992, Genes, chromosomes & cancer.

[28]  A. Chiò,et al.  Histologic prognostic factors in ependymoma , 1991, Child's Nervous System.

[29]  P. Barnes,et al.  The prognostic significance of postoperative residual tumor in ependymoma. , 1991, Neurosurgery.

[30]  L. Becker,et al.  Infratentorial ependymomas in childhood: prognostic factors and treatment. , 1990, Journal of neurosurgery.

[31]  M. Stratton,et al.  Cytogenetic abnormalities in human ependymomas , 1989, International journal of cancer.

[32]  R. Sanford,et al.  Ependymomas in children. , 1988, Pediatric neuroscience.

[33]  S B Green,et al.  Patient age, histologic features, and length of survival in patients with glioblastoma multiforme , 1987, Cancer.

[34]  A Brun,et al.  Tumours of the Central Nervous System , 1986, Acta radiologica: diagnosis.

[35]  H. Rodriguez,et al.  Multiple primary intracranial tumors in von Recklinghausen's neurofibromatosis. , 1966, Archives of neurology.

[36]  M. Wolter,et al.  Mutation of the PTEN (MMAC1) tumor suppressor gene in a subset of glioblastomas but not in meningiomas with loss of chromosome arm 10q. , 1998, Cancer research.

[37]  K. Matthay,et al.  Gain of chromosome 17 is the most frequent abnormality detected in neuroblastoma by comparative genomic hybridization. , 1997, The American journal of pathology.

[38]  P. Gerszten,et al.  Intracranial ependymomas of childhood. Lack of correlation of histopathology and clinical outcome. , 1996, Pathology, research and practice.

[39]  H. Bloom,et al.  Intracranial ependymoma: long-term results of a policy of surgery and radiotherapy. , 1992, International journal of radiation oncology, biology, physics.

[40]  L. Rorke,et al.  Prognostic factors in childhood ependymomas. , 1990, Pediatric neurosurgery.

[41]  L. J. Rubinstein,et al.  Lack of histopathological correlation of malignant ependymomas with postoperative survival. , 1989, Journal of neurosurgery.

[42]  H. Bloom,et al.  Tumours of the Central Nervous System , 1975 .